Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
NCT07045467
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Diseases
Renal Transplantation
Interventions
DRUG:
Remimazolam Besylate
Sponsor
Qianfoshan Hospital